Stem cell transplantation for type 1 diabetes mellitus


Autoria(s): Voltarelli, Júlio C; Couri, Carlos 
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

26/08/2013

26/08/2013

2009

Resumo

Abstract Background The use of stem cells to treat type 1 diabetes mellitus has been proposed for many years, both to downregulate the immune system and to provide β cell regeneration. Conclusion High dose immunosuppression followed by autologous hematopoietic stem cell transplantation is able to induce complete remission (insulin independence) in most patients with early onset type 1 diabetes mellitus.

Identificador

http://www.producao.usp.br/handle/BDPI/33189

10.1186/1758-5996-1-4

http://www.dmsjournal.com/content/1/1/4

Idioma(s)

eng

Relação

Diabetology & Metabolic Syndrome

Direitos

openAccess

Voltarelli and Couri; licensee BioMed Central Ltd. - This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Tipo

article

original article